VENTURELLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 9.900
EU - Europa 5.985
AS - Asia 5.626
SA - Sud America 747
AF - Africa 118
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.395
Nazione #
US - Stati Uniti d'America 9.730
IT - Italia 1.736
CN - Cina 1.701
SG - Singapore 1.674
GB - Regno Unito 1.447
DE - Germania 722
VN - Vietnam 686
BR - Brasile 576
SE - Svezia 574
HK - Hong Kong 511
FR - Francia 334
KR - Corea 271
RU - Federazione Russa 240
FI - Finlandia 210
UA - Ucraina 184
IN - India 145
PL - Polonia 109
TR - Turchia 109
CA - Canada 92
ID - Indonesia 86
JP - Giappone 83
BG - Bulgaria 72
BD - Bangladesh 62
NL - Olanda 62
AR - Argentina 59
BE - Belgio 57
IQ - Iraq 56
MX - Messico 47
ES - Italia 41
ZA - Sudafrica 35
IE - Irlanda 33
LT - Lituania 33
AE - Emirati Arabi Uniti 27
PK - Pakistan 26
UZ - Uzbekistan 26
CL - Cile 25
EC - Ecuador 24
AT - Austria 23
CH - Svizzera 22
SA - Arabia Saudita 20
IR - Iran 19
MY - Malesia 19
MA - Marocco 14
PH - Filippine 14
TW - Taiwan 14
CO - Colombia 13
JO - Giordania 13
VE - Venezuela 13
DZ - Algeria 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
PT - Portogallo 11
AU - Australia 10
KE - Kenya 10
PE - Perù 10
PY - Paraguay 10
TN - Tunisia 10
EG - Egitto 9
ET - Etiopia 9
RO - Romania 9
UY - Uruguay 9
BO - Bolivia 8
IL - Israele 8
KZ - Kazakistan 7
NP - Nepal 7
RS - Serbia 7
AL - Albania 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
NO - Norvegia 6
TH - Thailandia 6
DK - Danimarca 5
EU - Europa 5
SN - Senegal 5
GR - Grecia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
OM - Oman 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
CR - Costa Rica 3
GA - Gabon 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
LV - Lettonia 3
NI - Nicaragua 3
PA - Panama 3
QA - Qatar 3
SI - Slovenia 3
TZ - Tanzania 3
CI - Costa d'Avorio 2
GE - Georgia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
PS - Palestinian Territory 2
Totale 22.376
Città #
Singapore 1.018
Santa Clara 1.016
Ashburn 972
Southend 926
Fairfield 727
Hefei 620
Chandler 567
Woodbridge 501
Hong Kong 487
Houston 416
San Jose 414
Frankfurt am Main 335
Seattle 324
Ann Arbor 316
Jacksonville 315
Modena 315
Nyköping 308
Wilmington 280
Dearborn 264
Cambridge 263
Seoul 259
Beijing 245
Ho Chi Minh City 229
London 221
Los Angeles 181
New York 166
Hanoi 156
Chicago 148
Helsinki 131
Council Bluffs 126
The Dalles 110
Munich 85
San Diego 84
Lauterbourg 81
Milan 80
Moscow 80
Shanghai 79
Princeton 74
Sofia 70
São Paulo 69
Bologna 66
Jakarta 62
Kraków 62
Fremont 61
Orem 58
Eugene 54
Salt Lake City 53
Izmir 50
Boardman 46
Brussels 46
Tokyo 46
Buffalo 43
Redwood City 42
Warsaw 42
Dallas 40
Bremen 36
Guangzhou 36
Parma 33
Dublin 29
Grafing 29
Rome 29
Chennai 28
Da Nang 28
Denver 28
Manchester 27
Haiphong 26
Turku 26
Des Moines 25
Milwaukee 25
Elk Grove Village 24
Toronto 24
Tampa 23
Tashkent 23
Brooklyn 22
Reggio Emilia 22
Ottawa 21
Phoenix 21
Baghdad 20
Stockholm 20
Turin 20
Amsterdam 19
Kent 19
Montreal 19
Brescia 18
Johannesburg 18
Nanjing 18
Washington 18
Belo Horizonte 17
Boston 17
Sterling 17
Dhaka 16
Rio de Janeiro 16
Atlanta 15
Columbus 15
Padova 15
Dong Ket 14
Ferrara 14
Formigine 14
Paris 14
Hillsboro 13
Totale 14.800
Nome #
TYDOCK PHARMA s.r.l. Spin Off dell'Università di Modena e Reggio Emilia che ha come fine l'attività di ricerca e sviluppo nel settore delle biotech farmaceutiche. 647
An Improved Synthesis of CENTA, a Chromogenic Substrate for β-Lactamases 448
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 425
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 416
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 408
New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines 407
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 406
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 400
Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines 390
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 374
Structure-based studies on species-specific inhibition of thymidylate synthase 372
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 356
Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-beta-lactamases 351
Decoding the structural basis for carbapenem hydrolysis by class A β- lactamases: fishing for a pharmacophore 348
Multiligand approach to the identification of resistant strains overexpressing beta-lactamase 345
Allosteric Inhibition of human Thymidylate Synthase. 340
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 325
ANTICANCER DRUGS 322
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 321
Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors 318
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 316
Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents 310
Thymidylate synthase structure, function and implication in drug discovery 309
The Inhibition of Extended Spectrum beta-Lactamases: Hits and Leads 307
X-ray-crystallography deciphers the activity of broad spectrum boronic acid β-Lactamases inhibitors 306
IN SILICO/IN VITRO APPROACHES FOR THE IDENTIFICATION OF NEW CARBAPENEMASE INHIBITORS 305
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 295
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 293
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 292
Permeation through the cell membrane of a boron-based β-lactamase inhibitor. 288
Pirrole-amidine oligopeptide–DNA interaction studies through Isothermal Titration Calorimetry 282
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 282
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy 281
Optimization of N-alkylation in the Synthesis of Methotrexate and Pteridine-based Derivatives Under Microwave-Irradiation 277
Target-based approaches for the discovery of new antimycobacterial drugs 272
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 269
Long period fiber grating biosensor for the detection of drug resistant bacteria: The 'OPTObacteria' project 267
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 266
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 263
Crystallographic studies of novel inhibitors of [beta]-lactamases 263
Feasibility Study on a Measurement Method and a Portable Measuring System to Estimate the Concentration of Cloxacillin and β -Lactamase in Milk 263
A new strategy based on microwave-assisted technology for the extraction and purification of beeswax policosanols for pharmaceutical purposes and beyond 260
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 257
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 251
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 250
Naphthofuranone derivatives as specific inhibitors of thymidylate synthases 245
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 244
Label-free fiber optic optrode for the detection of class C beta-lactamases expressed by drug resistant bacteria 238
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 235
NAPHTHOFURANONE DERIVATIVES AS SPECIFIC INHIBITORS OF THYMIDYLATE SYNTHASES 235
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 234
Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative 232
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 230
Merging disulphide bonds for drug design Interfering with a cancer key protein 224
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 222
Developing New beta-Lactamase Inhibitors Through Structure-Based Design and Pharmacokinetic Improvement 221
Long period fiber grating working in reflection mode as valuable biosensing platform for the detection of drug resistant bacteria 217
Current Treatments to Control African Trypanosomiasis and One Health Perspective 208
Coupling a microwave-assisted process with HPLC-ELSD for the extraction, purification and analysis of bioactive policosanols from beeswax 202
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 198
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 197
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 192
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 187
An innovative method for the extraction and HPLC analysis of bioactive policosanols from non-psychoactive Cannabis sativa L. 185
Quinoxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]- benzoylglutamates and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]- benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activities 185
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation 184
Structural and thermodynamic combined studies for inhibitors binding to Thymidylate Synthase 184
Nuovo trattamento assistito da microonde per la produzione di miscele arricchite in policosanoli da matrici cerose 184
Structural and Thermodynamic analysis of novel inhibitors of beta-lactmases. 183
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 180
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 173
Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases 172
Expression, purification, and characterization of Transcriptional Enhancer Associated Domain (hTEAD4), a promising target for anticancer agents 170
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective 169
Studi termodinamici e strutturali dell’interazione tra derivati densilici e Timidilato Sintasi Batteriche 167
On the feasibility of a CENTA-based biosensor to measure antibiotics concentration in milk 166
VIrtual screening identifies cross-class inhibitors of clinically relevant serine- and metallo-beta lactamases 164
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 158
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents 153
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 146
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 140
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1 132
First total synthesis of the irciniasulfonic acids 130
Reflection-type long period grating biosensor for the detection of drug resistant bacteria: The Opto-bacteria Project 127
Reflection-type long period grating biosensor for detection of drug resistant bacteria: The OptoBacteria project 123
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 122
On the feasibility of a CENTA-based biosensor to measure antibiotics concentration in milk 118
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 73
Totale 22.592
Categoria #
all - tutte 81.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 0 0 0 0 0 170 91
2021/20221.483 56 135 83 63 82 151 70 89 180 110 297 167
2022/20231.837 237 223 136 174 176 245 72 152 243 25 79 75
2023/20241.643 71 90 116 111 543 146 55 142 36 32 143 158
2024/20254.253 154 45 137 249 767 555 311 254 435 180 553 613
2025/20266.957 536 415 597 949 1.192 496 954 336 646 696 140 0
Totale 22.592